mdlinx mdlinx

Endocrinology - Diabetes News & Articles

MDLinx Endocrinology Overview: Our medical editors have ranked and organized papers in the top peer-reviewed clinical journals by topic including diabetes types 1 and 2, thyroid and glandular diseases, obesity and dyslipidemia. In a matter of minutes, you and all the members of your patient care team can stay current on the literature as it is published.

Also on this page: MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD, and clinical pearls from The Smartest Diabetes Expert as well as endocrinology topics in The Smartest Internist, The Smartest Family Physician, and The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Endocrinology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Articles

Latest (16) Full Text Articles (1230) Focus on Diabetes
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

861 Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry Pediatric Diabetes, March 18, 2013    Review Article

862 Characteristics of Diabetes Associated With Poor Improvements in Clinical Outcomes After Lumbar Spine Surgery Spine, March 18, 2013    Evidence Based Medicine

863 Suppressive effect of aqueous humor from person with Type 2 diabetes with or without retinopathy on reactive oxygen species generation Diabetes Research and Clinical Practice, March 18, 2013    Review Article

864 White Matter Tract Integrity of Anterior Limb of Internal Capsule in Major Depression and Type 2 Diabetes Neuropsychopharmacology, March 18, 2013    Review Article

865 Impaired vibrotactile sense at low frequencies in fingers in autoantibody positive and negative diabetes Diabetes Research and Clinical Practice, March 18, 2013    Review Article

866 Incretin therapy for type 2 diabetes: GLP-1 receptor agonists and DPP-4 inhibitors European Diabetes Nursing, March 18, 2013    Clinical Article

867 A simplified indication of metabolic syndrome to recognize subjects with a moderate risk to develop type 2 diabetes mellitus in a large Italian sample Acta Diabetologia, March 18, 2013    Clinical Article

868 N-terminal pro-brain natriuretic peptide could be a marker of subclinical atherosclerosis in patients with type 2 diabetes Heart and Vessels, March 18, 2013    Clinical Article

869 Diabetes and everolimus-eluting stents: what we know and what is still missing. Insights from subanalysis of the SORT OUT IV trial Expert Review of Cardiovascular Therapy , March 18, 2013    Review Article

870 Developing, implementing and evaluating diabetes care training for nurses and nursing aides in nursing homes and municipal home-based services European Diabetes Nursing, March 18, 2013    Clinical Article

871 Diabetes and thyroid cancer mortality: a 12-year prospective follow-up of Taiwanese European Journal of Clinical Investigation, March 18, 2013    Review Article

872 Effect of varying accelerometry criteria on physical activity: The look ahead study Obesity, March 18, 2013    Review Article

873 Japan Diabetic Nephropathy Cohort Study: study design, methods, and implementation Clinical and Experimental Nephrology, March 18, 2013    Clinical Article

874 Patients newly diagnosed with clinical type 2 diabetes mellitus but presenting with HbA1c within normal range: 19-Year mortality and clinical outcomes Primary Care Diabetes, March 15, 2013    Review Article

875 Longitudinal changes in dietary fat intake and associated changes in cardiovascular risk factors in adults with type 2 diabetes: The ACCORD trial Diabetes Research and Clinical Practice, March 15, 2013    Clinical Article

876 The Effect of Chronic Twice Daily Exenatide Treatment on β-cell Function in New Onset Type 2 Diabetes Clinical Endocrinology, March 15, 2013    Clinical Article

877 A randomised trial of enteric-coated nutrient pellets to stimulate gastrointestinal peptide release and lower glycaemia in type 2 diabetes Diabetologia - Clinical and Experimental Diabetes and Metabolism, March 15, 2013    Clinical Article

878 The use of insulin analogues in pregnancy Diabetes, Obesity and Metabolism, March 15, 2013    Review Article

879 Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: A randomized, open label study Diabetes Research and Clinical Practice, March 15, 2013    Clinical Article
Exclusive Author Commentary

880 Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes Full Text Cardiovascular Diabetology, March 15, 2013    Clinical Article

50 available pages First Previous 41 42 43 44 45 46 47 48 49 50 Next Last

Clinical Pearls in Endocrinology

Highlights in Endocrinology

Regulatory protein identified in T1DM

As published in Pancreas, researchers at the Bowman Gray School of Medicine have identified a protein (islet homeostasis protein [IHoP]) which appears to control blood glucose levels by regulating the balance between insulin and glucagon. IHoP is released from glucagon-producing cells in the islets. In both humans and animals, high levels of IHoP exist in the euglycemic state, while T1DM is associated with an absence of IHoP. The authors suggest that IHoP may serve as a target in the treatment of T1DM.

Read the article summary

Statins increase risk of DM in postmenopausal women

As reported in the Archives of Internal Medicine, researchers at the Mayo Clinic have shown an association between statin use and diabetes mellitus in postmenopausal women. The study involved 161,808 postmenopausal women (age range, 50-79 years) who were enrolled at 40 centers between 1993 and 1998 as part of the Women’s Health Initiative. Of the study cohort, data was available for 153,840 women without diabetes at baseline, 7.04% of whom used statins. There were 10,242 incident cases of diabetes in statin users (HR = 1.71) during 1,004,466 person-years of follow-up

Read the article summary

Determining the basal insulin dosage in T2DM

Anthropometric, laboratory, and clinical findings were evaluated in 681 patients with type 2 diabetes mellitus to determine the factors with the greatest influence on determining the basal insulin dosage for a target glucose level < 120 mg/dL. The authors reported that waist circumference, the duration of insulin treatment, lipid-lowering medications, use of insulin sensitizers, the HbA1c, fasting plasma glucose, HDL-C, and triglycerides levels, and severe NAFLD were most significant.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Endocrinology Articles

Last month's top read Top Articles of 2012

Indexed Journals in Endocrinology: Endocrinology, Journal of Endocrinology, Clinical Endocrinology, Diabetesmore

Other Topics in Endocrinology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close